{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"AR (androgen receptor), a transcription factor, is most frequently altered in advanced or castration-resistant prostate cancer.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"11/16/2020",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "25500996"
      ]
    },
    "description":"The AR Q58_Q59insL mutation is located in the amino-terminal domain of the protein. This mutation was found in the germline of an individual with minor androgen insensitivity syndrome. Expression of this mutation in a simian cell line demonstrated that it is likely inactivating as measured by decreased AR transcriptional activity compared to wildtype (PMID: 25500996).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Neutral",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"L57_Q58insLQQQQQQQQ",
    "alterationType":null,
    "consequence":null,
    "entrezGeneId":367,
    "hgvs":null,
    "hugoSymbol":"AR",
    "id":null,
    "proteinEnd":null,
    "proteinStart":null,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The AR L57_Q58insLQQQQQQQQ alteration is likely neutral.",
  "vus":false
}